Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The phase 2 semaglutide NASH trial (published in NEJM, 2021) demonstrated NASH resolution in a significant proportion of patients, though fibrosis improvement was modest
Moreover, both patients and doctors reported significant disease improvements among participants
The timelines for every formulation type
Some patients experience temporary symptom fluctuations during the first week after discontinuation before improvement occurs
US$ 26.66
US$ 20.04
US$ 27.49
US$ 24.15
US$ 23.57
US$ 26.95
